Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?

European Journal of Gynaecological Oncology

Volumn 27, Issue 2, 2006, Pages 177-178

  Cirpan, T ^a   Akercan, F ^a   Itil, I M ^a   Gundem, G ^a   Bilgen, I ^a   Yucebilgin, M S ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Mammography; Raloxifene

Indexed keywords

RALOXIFENE;

ADULT; ARTICLE; BONE DENSITY; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; SCORING SYSTEM; TIME;

ADULT; BONE DENSITY CONSERVATION AGENTS; BREAST; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RALOXIFENE; RETROSPECTIVE STUDIES;

EID: 33645972232     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sendag F., Cosan T.M., Ozsener S., Oztekin K., Bilgin O., Bilgen I., Memis A.: "Mammographic density changes during different postmenopausal hormone replacement therapies". Fertil. Steril., 2001, 76, 445.
2. Sendag F., Terek M.C., Ozsener S., Oztekin K.: "Mammographic density changes in postmenopausal women using tibolone therapy". Int. J. Gynaecol. Obstet., 2001, 74, 63.
3. Howell A.: "Antiestrogenes: Future prospects". Oncology, 1997, 11, 59.
4. Levenson A.S., Jordan V.C.: "The key to antiestrogenic mechanism of raloxifene is aminoacid 351 (aspartate) in the estrogene receptor". Cancer Res., 1998, 58, 1872.
5. Frisell J., Lidbrink E., Hellstrom L., Rutqvist L.E.: "Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial". Breast Cancer Res. Treat., 1997, 45, 263.
6. Bjurstam N., Bjorneld L., Duffy S.W., Smith T.C., Cahlin E., Eriksson O. et al.: "The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization". Cancer, 1997, 80, 2091.
7. Bird R.E., Wallace T.W., Yankaskas B.C.: "Analysis of cancers missed at screening mammography". Radiology, 1992, 184, 613.
8. Ma L., Fishell E., Wright B., Hanna W., Allan S., Boyd N.F.: "Case-control study of factors associated with failure to detect breast cancer by mammography". J. Natl. Cancer Inst., 1992, 84, 781.
9. rd edition, Reston, VA, American College of Radiology, 1998.
10. Nishikawa R.M., Giger M.L., Doi K., Metz C.E., Yin F.F., Vyborny C.J. et al.: "Effect of case selection on the performance of computeraided detection schemes". Med. Phys., 1994, 21, 265.
11. Mandelson M.T., Oestreicher N., Porter P.L., White D., Finder C.A., Taplin S. et al.: "Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers". J. Natl. Cancer Inst., 2000, 92, 1081.
12. Jackson V.P., San Martin J.A., Secrest R.J., McNabb M., Carranza-Lira S., Figueroa-Casas P. et al.: "Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women". Am. J. Obstet. Gynecol., 2003, 188, 389.